Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Women with breast cancer, who have undergone treatment to eradicate the abnormal cell growth and come out on the other side as a survivor, can experience a complex set of challenges as they recover. In particular, there can be complex emotional and physical changes to face as they continue with their lives. Learning to adjust to these changes can be stressful, and every woman will respond differently.
The latest study on hormone therapy and Alzheimer's disease shows no relationship between taking the drugs and whether you may develop the disease years later.
Written by Yolanda Smith, BPharm For women who are at high risk of developing ovarian breast cancer, prophylactic bilateral oophorectomy to remove the ovaries on both sides and reduce the risk of these cancers may be indicated. The procedure is primarily performed to reduce the risk of ovarian cancer, although it is also associated with a reduced risk of breast cancer.
Hormone receptor-positive (HR-positive or HR+) breast cancer is a type of breast cancer that feeds on the presence of estrogen and progesterone hormones in the body to grow. This type of breast cancer can be targeted with hormonal treatments to slow down the growth of the cancer cells or reduce the risk of recurrence.
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of
our websites
and requested to be notified of additional information.
